Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Virginia Borges

Breast Oncology · CU Anschutz Medical Campus

View

Dr. William Gradishar

Breast Oncology · NU

View

Dr. Jame Abraham

Breast Oncology · Cleveland Clinic

View

Dr. Amy Comander

Breast Oncology · PHS

View

Dr. Paolo Tarantino

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Anastasia Martynova

Breast Oncology · USC

View

Dr. Rani Bansal

Breast Oncology · Duke

View

Dr. Gilbert Bader

Breast Oncology · OSUMC

View

Dr. VK Gadi

Breast Oncology · UI Health

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    AADr. Azka Ali
    Leading Voice

    Dr. Azka Ali

    Hematology & Oncology · Breast Oncology
    Cleveland Clinic Lerner College of Medicine
    drazkaali
    Cleveland, OH
    Aug 20, 2025Journal Article

    Neoadjuvant Chemotherapy is Associated with Worse 5-Year Overall Survival in Patients with Metaplastic Breast Cancer Compared with Primary Surgery: A National Cancer Database Analysis.

    ​
    ​

    Written by 2 Roon authors & 6 others

    Via Annals of Surgical Oncology

    Research

    Clinical and genomic factors associated with elacestrant outcomes in ESR1-mutant metastatic breast cancer.

    2025

    Via Clinical Cancer Research

    Aug 20, 2025Journal Article

    Neoadjuvant Chemotherapy is Associated with Worse 5-Year Overall Survival in Patients with Metaplastic Breast Cancer Compared with Primary Surgery: A National Cancer Database Analysis.

    ​
    ​

    Written by 2 Roon authors & 6 others

    Via Annals of Surgical Oncology

    Research

    Clinical and genomic factors associated with elacestrant outcomes in ESR1-mutant metastatic breast cancer.

    2025

    Via Clinical cancer research : an official journal of the American Association for Cancer Research

    Research

    An Unusual Case of Apixaban-Induced Small Vessel Vasculitis: Leukocytoclastic Vasculitis.

    2024

    Via Cureus

    Research

    Locoregional recurrence in triple negative breast cancer: past, present, and future.

    2023

    Via Expert Review of Anticancer Therapy

    Research

    Exploring DESTINY: the Past, Present, and Future of Trastuzumab Deruxtecan.

    2023

    Via Current Oncology Reports

    Research

    Cerebral Sinus Thrombosis and Immune Thrombocytopenia Post COVID-19 Vaccination: A Case Report and Narrative Review.

    2023

    Via Cureus

    Research

    A Case of Thrombotic Thrombocytopenic Purpura and ST-Elevation Myocardial Infarction: An Unusual Correlation.

    2023

    Via Cureus

    Research

    Locoregional recurrence in triple negative breast cancer: past, present, and future.

    2023

    Via Expert review of anticancer therapy

    Research

    Exploring DESTINY: the Past, Present, and Future of Trastuzumab Deruxtecan.

    2023

    Via Current oncology reports

    Research

    Endocrine adherence in male versus female breast cancer: a seer-medicare review.

    2022

    Via Breast Cancer Research and Treatment

    Research

    Emergence of ocular toxicities associated with novel anticancer therapeutics: What the oncologist needs to know.

    2022

    Via Cancer Treatment Reviews

    Research

    Atezolizumab plus tivozanib for immunologically cold tumor types: the IMMCO-1 trial.

    2022

    Via Future Oncology

    Research

    Endocrine adherence in male versus female breast cancer: a seer-medicare review.

    2022

    Via Breast cancer research and treatment